English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Evaluation of Efficacy and Safety of Nivolumab and Pembrolizumab in Elderly Cancer Patients Hye Sung Kim, HyoKeun Jeong, and Mi Kyong Shim* Graduate School of Clinical Pharmacy, Cha University, Gyeonggi-do 11160, Republic of Korea Veterans’ Health Service Medical Center, Seoul 05368, Republic of Korea College of Pharmacy, Cha University, Gyeonggi-do 11160, Republic of Korea (Received August 29, 2019 · Revised February 24, 2020 · Accepted February 26, 2020)